Rayno Diagnostics and Tools Portfolio Prices as of 5/29/13
- Top 2013 Winners: ABAX, ALR, CSII, GHDX, ILMN, TMO, VRML
- Sector high was in mid-May
- Less volatile than biopharma but more dependent on earnings
- Five companies on focus list were acquired over 3 years
2010-2013 | Original | Price | Price | % | Price | Price | % RET | Price | %RET | |||
DX and Tools | Recomm | Dec’10 | Ret | 10/2/12 | 1/2/13 | 1 yr | 5/29/13 | YTD | ||||
Abaxis | ABAX | 2/2/09 | 15 | 26.9 | 79 | 37.9 | 37.8 | 36.7 | 44.7 | 18.2 | ||
BG Medicine | BGMD | 5/15/13 | 1.73 | NEW | 2.32 | -58 | 1.83 | 5.8 | ||||
CardioV.Sys. | CSII | 11/5/10 | 7.15 | 11.7 | 63 | 11.45 | 13 | 29.7 | 19.88 | 53 | ||
Celera | CRA | 3/28/10 | 7 | 6.3 | 18 | acquired | ||||||
Cepheid | CPHD | 10/23/12 | 31.4 | NEW | 35.5 | 13 | 37.33 | 5 | ||||
Exact Sci | EXAS | 12/10/10 | 5.6 | 5.98 | 6.8 | 11.36 | 11 | 36 | 11.12 | 1 | ||
GenomicH | GHDX | 2/26/13 | 28.5 | NEW | 27.24 | 6.3 | 37 | 35.6 | ||||
GenProbe | GPRO | 2/2/09 | 45 | 58.4 | 30 | 82.55 | acquired | |||||
Hologic | HOLX | 4/9/13 | 21.6 | NEW | 20 | 20.17 | -6.5 | |||||
Illumina | ILMN | 2/2/09 | 29 | 63.3 | 118 | 51.2 | 55.4 | 81.8 | 71 | 27 | ||
Immucor | BLUD | 4/5/10 | 20 | 19.8 | 0 | acquired | ||||||
Alere | ALR | 2/2/09 | 25 | 36.6 | 46 | 19.64 | 19 | -18 | 25.37 | 33.5 | ||
MicroFluidics | MFLU | 7/6/10 | 0.77 | 1.34 | 74 | acquired | ||||||
NeoGen | NEOG | 7/2/10 | 26 | 41 | 58 | 42.8 | 45.6 | 48.8 | 55.15 | 21 | ||
Qiagen | QGEN | 3/15/10 | 21.5 | 19.6 | -9 | 19 | 18.8 | 36 | 18.91 | 0 | ||
Quidel | QDEL | 6/16/10 | 12.4 | 14.5 | 16 | 18.65 | 19.9 | 31.3 | 23.15 | 16.3 | ||
ResponseG | RGDX | 2/3/12 | 1.5 | 1.3 | 1.4 | -13 | 1.49 | 6 | ||||
Sequenom | SQNM | 11/18/09 | 3.75 | 8.03 | 114 | 3.5 | 4.93 | 10.8 | 4.04 | -23 | ||
SeraCare | SRLS | 11/18/09 | 2.75 | 4.75 | 73 | acquired | ||||||
ThermoFish | TMO | 7/25/12 | 53.5 | NEW | 59.4 | 65 | 44.5 | 87.36 | 34 | |||
Vermillion | VRML | 5/15/13 | 2.53 | NEW | 1.37 | 73 | 3.71 | 47 | ||||
Rayno Biopharmaceuticals Portfolio After 6.5% IBB Correction Since May 21
- Top 2013 Winners: AMRI, ASTX, BIIB, GILD, PCYC, SGEN All Over 30% YTD
- Sector High was in mid may May IBB 187
- Two 2013 Losers: ACHN (new), ALXN off 8%
- Volatility due to hedge fund investing and momentum trades
2013 | Price | Original | P | Price | %Ret | Price | Price | % Ret | Price | |||
Summary | Jy’10 | Recomm | Dec’10 | 2010 | Apr’11 | Dec’12 | YTD’13 | 20-Jun | ||||
Achillion | ACHN | 3/4/13 | 8.6 | -8.1 | 7.9 | |||||||
Alexion | ALXN | 50.45 | 2/2/09 | 35 | 80.6 | 130 | 100.8 | 95.4 | -8 | 88.47(sp) | ||
Alkermes | ALKS | added | 3/22/13 | 23 | 18.5 | 17 | 27 | |||||
Albany Mol | AMRI | 2/10/11 | 4.68 | added | 4.32 | 5.3 | 116 | 11.46 | ||||
Astex | ASTX | 12/27/11 | 1.63 | 2.7 | 67 | 4.5 | ||||||
Amgen | AMGN | 51.7 | 2/2/09 | 55 | 54.9 | 0 | 54 | 87.4 | 10 | 96.28 | ||
Biogen | BIIB | 49.42 | 2/2/09 | 48.5 | 67.1 | 37 | 73.25 | 149 | 33 | 199.58 | ||
Cephalon | CEPH | 55.95 | 2/2/09 | 76.5 | 61.7 | -19 | 76.92 | 80.18 | 30 | acquired | ||
Cubist | CBST | 20.7 | 2/2/09 | 21.5 | 21.4 | -3 | 28.35 | 42.4 | 15 | 49 | ||
Exelixis | EXEL | trade | 9/2/10 | 3.3 | 8.21 | 148 | 11.12 | 4.58 | 0 | 4.56 | ||
First Trust | FBT | 30.4 | 4/15/10 | 37.5 | 39.1 | 3 | 41.3 | 46 | 19.5 | 55.1 | ||
Gilead | GILD | 34.9 | 2/2/09 | 51 | 36.2 | -29 | 42.81 | 72.7 | 34 | 49.38(sp) | ||
iShares ETF | IBB | 76.6 | 2/2/09 | 70.5 | 93.4 | 32 | 101.1 | 137.8 | 22 | 167.92 | ||
SPDR Bio | XBI | 86.38 | 17.4 | 101.29 | ||||||||
Micromet | MITI | 6.28 | 2/2/09 | 4 | 8.12 | 103 | 5.46 | 10.91 | 272 | acquired | ||
ImmunoGen | IMGN | 12/22/11 | 12.4 | 12.5 | 23 | 15.37 | ||||||
Optimer | OPTR | trade | 2/18/11 | 11.8 | added | 13.8 | 9.2 | 51.6 | 13.72 | |||
Pharmacycl | PCYC | 6/8/12 | 38.2 | 58 | 40 | 81.29 | ||||||
Regeneron | REGN | 21.6 | 2/2/09 | 17.5 | 32.8 | 82 | 45.43 | 173 | 28.3 | 219.61 | ||
Seattle Gen. | SGEN | 11.85 | 2/2/09 | 9.5 | 15 | 57 | 15.72 | 23.3 | 33 | 31.01 | ||
ViroPharma | VPHM | 10.88 | 2/2/09 | 12 | 17.3 | 44 | 20.05 | 22.9 | 22 | 27.9 | ||
Paired Trades | ||||||||||||
Pharmacycl | PCYC | long | 6/8/12 | 38.2 | 60 | 51 | 81.29 | |||||
Medivation | MDVN | short | 6/8/12 | 86.8 | closed | 50 | 7 | 45.21(split) | ||||
net | 58 | |||||||||||
Alkermes | ALKS | long | 3/22/13 | 23 | 18.5 | 27 | 27 | |||||
Infinity | INFI | short | 3/22/13 | 48.7 | closed | 35 | 18 | 18.36 | ||||
net | 45 |